One study focusing solely on esophageal adenocarcinomas showed that the chemoresistance was conveyed through alteration of the Wnt/β-catenin pathway and DKK2, CDH1, CD44, MYC, and ABCG2 expression [26]. This evidence concerns the gene ABCG2 and esophageal adenocarcinoma.